Recent strategies in spray drying for the enhanced bioavailability of poorly water-soluble drugs

被引:116
作者
Davis, Mark [1 ]
Walker, Gavin [2 ]
机构
[1] Univ Limerick, Bernal Inst, Synth & Solid State Pharmaceut Ctr SSPC, Limerick, Ireland
[2] Univ Limerick, Bernal Inst, Limerick, Ireland
基金
爱尔兰科学基金会;
关键词
Spray drying; Solid dispersion; Amorphous; Poorly soluble drugs; Formulation; AMORPHOUS SOLID DISPERSIONS; HOT-MELT EXTRUSION; ACTIVE PHARMACEUTICAL INGREDIENTS; RESPONSE-SURFACE MODEL; IN-VIVO EVALUATION; CLASS-II DRUG; DRIED DISPERSIONS; ORAL DELIVERY; PHYSICAL STABILITY; PHASE-BEHAVIOR;
D O I
10.1016/j.jconrel.2017.11.005
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Poorly water-soluble drugs are a significant and ongoing issue for the pharmaceutical industry. An overview of recent developments for the preparation of spray-dried delivery systems is presented. Examples include amorphous solid dispersions, spray dried dispersions, microparticles, nanoparticles, surfactant systems and self-emulsifying drug delivery systems. Several aspects of formulation are considered, such as pre-screening, choosing excipient(s), the effect of polymer structure on performance, formulation optimisation, ternary dispersions, fixed-dose combinations, solvent selection and component miscibility. Process optimisation techniques including nozzle selection are discussed. Comparisons are drawn with other preparation techniques such as hot melt extrusion, freeze drying, milling, electro spinning and film casting. Novel analytical and dissolution techniques for the characterization of amorphous solid dispersions are included. Progress in understanding of amorphous supersaturation or recrystallisation from solution gathered from mechanistic studies is discussed. Aspects of powder flow and compression are considered in a section on downstream processing. Overall, spray drying has a bright future due to its versatility, efficiency and the driving force of poorly soluble drugs.
引用
收藏
页码:110 / 127
页数:18
相关论文
共 179 条
[31]   Oral Delivery of Highly Lipophilic Poorly Water-Soluble Drugs: Spray-Dried Dispersions to Improve Oral Absorption and Enable High-Dose Toxicology Studies of a P2Y1 Antagonist [J].
Chen, Xue-Qing ;
Stefanski, Kevin ;
Shen, Hong ;
Huang, Christine ;
Caporuscio, Christian ;
Yang, Wu ;
Lam, Patrick ;
Su, Ching ;
Gudmundsson, Olafur ;
Hageman, Michael .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2014, 103 (12) :3924-3931
[32]   Initial Drug Dissolution from Amorphous Solid Dispersions Controlled by Polymer Dissolution and Drug-Polymer Interaction [J].
Chen, Yuejie ;
Wang, Shujing ;
Wang, Shan ;
Liu, Chengyu ;
Su, Ching ;
Hageman, Michael ;
Hussain, Munir ;
Haskell, Roy ;
Stefanski, Kevin ;
Qian, Feng .
PHARMACEUTICAL RESEARCH, 2016, 33 (10) :2445-2458
[33]   Physical characterization and stability of amorphous indomethacin and ranitidine hydrochloride binary systems prepared by mechanical activation [J].
Chieng, Norman ;
Aaltonen, Jaakko ;
Saville, Dorothy ;
Rades, Thomas .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2009, 71 (01) :47-54
[34]   Dabigatran versus Warfarin in Patients with Atrial Fibrillation. [J].
Connolly, Stuart J. ;
Ezekowitz, Michael D. ;
Yusuf, Salim ;
Eikelboom, John ;
Oldgren, Jonas ;
Parekh, Amit ;
Pogue, Janice ;
Reilly, Paul A. ;
Themeles, Ellison ;
Varrone, Jeanne ;
Wang, Susan ;
Alings, Marco ;
Xavier, Denis ;
Zhu, Jun ;
Diaz, Rafael ;
Lewis, Basil S. ;
Darius, Harald ;
Diener, Hans-Christoph ;
Joyner, Campbell D. ;
Wallentin, Lars .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (12) :1139-1151
[35]   Pharmaceutical applications of hot-melt extrusion: Part I [J].
Crowley, Michael M. ;
Zhang, Feng ;
Repka, Michael A. ;
Thumma, Sridhar ;
Upadhye, Sampada B. ;
Battu, Sunil Kumar ;
McGinity, James W. ;
Martin, Charles .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2007, 33 (09) :909-926
[36]   Systemic in vitro and in vivo evaluation for determining the feasibility of making an amorphous solid dispersion of a B-Raf (rapidly accelerated fibrosarcoma) inhibitor [J].
Cui, Yong ;
Chiang, Po-Chang ;
Choo, Edna F. ;
Boggs, Jason ;
Rudolph, Joachim ;
Grina, Jonas ;
Wenglowsky, Steve ;
Ran, Yingqing .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2013, 454 (01) :241-248
[37]   Utility of Hydroxypropylmethylcellulose Acetate Succinate (HPMCAS) for Initiation and Maintenance of Drug Supersaturation in the GI Milieu [J].
Curatolo, William ;
Nightingale, James A. ;
Herbig, Scott M. .
PHARMACEUTICAL RESEARCH, 2009, 26 (06) :1419-1431
[38]   The Twofold Advantage of the Amorphous Form as an Oral Drug Delivery Practice for Lipophilic Compounds: Increased Apparent Solubility and Drug Flux Through the Intestinal Membrane [J].
Dahan, Arik ;
Beig, Avital ;
Ioffe-Dahan, Viktoriya ;
Agbaria, Riad ;
Miller, Jonathan M. .
AAPS JOURNAL, 2013, 15 (02) :347-353
[39]   Solution-State Polymer Assemblies Influence BCS Class II Drug Dissolution and Supersaturation Maintenance [J].
Dalsin, Molly C. ;
Tale, Swapnil ;
Reineke, Theresa M. .
BIOMACROMOLECULES, 2014, 15 (02) :500-511
[40]   Design of spray dried ternary solid dispersions comprising itraconazole, soluplus and HPMCP: Effect of constituent compositions [J].
Davis, Mark T. ;
Potter, Catherine B. ;
Mohammadpour, Maryam ;
Albadarin, Ahmad B. ;
Walker, Gavin M. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2017, 519 (1-2) :365-372